2021

Almirall and Tyris Therapeutics develop next generation gene therapies
07/01/2021

Barcelona / Valencia, January 2021.- Almirall, a global biopharmaceutical company based in Barcelona, and Tyris Therapeutics, a next generation gene therapy company... Read More
Aura Biosciences Appoints David Johnson to Its Board of Directors
05/01/2021

CAMBRIDGE, Mass.--Aura Biosciences, a clinical-stage oncology company developing a novel class of drug conjugate therapies for multiple oncology indications, today announced... Read More